![](https://scx1.b-cdn.net/csz/news/tmb/2024/asco-ivonescimab-impro.jpg)
Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer
For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the ...
Jun 6, 2024
0
18